Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Axsome Thera (NQ: AXSM )

75.92 USD UNCHANGED
Streaming Delayed Price Updated: 5:14 PM EST, Jan 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Axsome Thera

< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
VistaGen Is Prepared For 2021 Fueled By Recent Analyst Upgrades And Large Institutional Buyers
VistaGen’s deal with Pherin Pharmaceuticals to develop PH-94B has positioned the Company to grab a healthy share of, social anxiety, and major depression markets. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Benzinga's Top Upgrades, Downgrades For January 8, 2021
Upgrades For Newell Brands Inc (NASDAQ:NWL), B of A Securities upgraded the previous rating of Neutral to Buy. Newell ... 
Tags Initiation Benzinga VOYA
From Benzinga
Analysts Predict 15% Upside For The Holdings of IHE
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Axsome Therapeutics Initiates ACCORD Phase 3 Trial of AXS-05 in Alzheimer’s Disease Agitation
From GlobeNewswire News Releases
Axsome Therapeutics Announces Positive Efficacy and Safety Results from the Phase 3 MOVEMENT Long-Term Trial of AXS-07 in the Acute Treatment of Migraine
From GlobeNewswire News Releases
Noteworthy Tuesday Option Activity: BJRI, AXSM, GILD
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BJ's Restaurants Inc (BJRI), where a total of 1,894 contracts have traded so far,... 
Tags Stocks
From Market News Video
3 Biotech Stocks That Could Explode Higher in 2021
Here's how three nascent drugmakers could make 2021 a banner year for your portfolio. 
Tags CRSP VRTX ALXN
From Motley Fool
Benzinga's Top Upgrades, Downgrades For December 16, 2020
Upgrades For Amplify Energy Corp (NYSE: AMPY), Roth Capital upgraded the previous rating of Neutral to the current rating Buy. For ... 
Tags KOS WAT NKLA
From Benzinga
Notable Monday Option Activity: AXSM, TTWO, HUM
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Axsome Therapeutics Inc (AXSM), where a total volume of 2,556 contracts has been... 
Tags Stocks
From Market News Video
11.4% of XPH Holdings Seeing Recent Insider Buys
A look at the weighted underlying holdings of the SPDR— S&P— Pharmaceuticals ETF (XPH) shows an impressive 11.4% of holdings on a weighted basis have experienced insider buying within the past six... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CDNA NEO GH
From Benzinga
Axsome Therapeutics Announces Positive Results from the COMET-SI Trial of AXS-05 in Patients with Major Depressive Disorder Who Have Suicidal Ideation
From GlobeNewswire News Releases
The Math Shows IHE Can Go To $210
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Stocks Generating Improved Relative Strength: Axsome Therapeutics
A Relative Strength Rating upgrade for Axsome Therapeutics shows improving technical performance. Will it continue? 
From Investor's Business Daily
Noteworthy Thursday Option Activity: AXSM, NTLA, SKT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Axsome Therapeutics Inc (AXSM), where a total of 1,882 contracts have traded so far,... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ZLAB INBX NTRA
From Benzinga
Axsome Therapeutics Announces Positive Results from the COMET-TRD Trial of AXS-05 in Patients with Treatment Resistant Depression
From GlobeNewswire News Releases
Why These 4 Pharma Stocks Are Moving Today
BioNTech (NASDAQ: BNTX) shares are trading lower on Tuesday after Bank Of America downgraded the stock from Buy to Neutral. BioNTech ... 
Tags Trading Ideas News MDRX
From Benzinga
Axsome Therapeutics Announces Positive Efficacy and Safety Results from Phase 3 COMET Long-Term Trial and COMET-AU Trial of AXS-05 in Major Depressive Disorder
From GlobeNewswire News Releases
5 Under-the-Radar Tickers That Will Stomp the Market in 2021
Investors are hyper-focused on COVID-19 right now, but once vaccines for the virus have been approved, other healthcare stocks will start to zoom forward. 
Tags NVAX BLUE BPMC
From Motley Fool
Bullish Two Hundred Day Moving Average Cross - AXSM
In trading on Wednesday, shares of Axsome Therapeutics Inc (AXSM) crossed above their 200 day moving average of $76.20, changing hands as high as $77.48 per share. Axsome Therapeutics Inc shares are... 
Tags Stocks
From Market News Video
On the Trail of Better Therapeutics for Depression
From InvestorBrandNetwork
On the Trail of Better Therapeutics for Depression
NetworkNewsWire Editorial Coverage 
From PR Newswire
Notable Thursday Option Activity: BLUE, GES, AXSM
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in bluebird bio Inc (BLUE), where a total volume of 3,937 contracts has been traded... 
Tags Stocks
From Market News Video
Add Up The Parts: JKJ Could Be Worth $185
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Axsome Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
11.7% of JKJ Holdings Seeing Recent Insider Buys
A look at the weighted underlying holdings of the iShares Morningstar Small-Cap ETF (JKJ) shows an impressive 11.7% of holdings on a weighted basis have experienced insider buying within the past six... 
Tags ETFs
From ETF Channel
Electrotherapy: Medical Company Medical Company Leaders MedTronic PLC (NYSE: MDT), Electromedical Technologies, Inc. (OTCQB: EMED) And Abbott Laboratories (NYSE: ABT) Offer Solutions for Chronic Pain
Tags Financial Content IPS Reportedtimes
From iCrowdNewswire
Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ Platform
From GlobeNewswire News Releases
Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ Platform
Axsome and Veeva announced a strategic partnership to augment the build of Axsome’s Digital-Centric Commercialization (DCC™) platform. 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
20 21 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.